FDA Warns of Seizure Risk With Some Parkinson’s Drugs
(MedPage Today) -- The FDA issued a safety communication today warning of a potential increased risk of seizures tied to ...
Tag: Drugs
Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concern: Lancet
Perfect-looking counterfeit Ozempic, with fake labels and boxes, make it near impossible to decipher what is real and what is ...
West Asia conflict disrupts pharma air routes; risks cancer drugs supply
Executives at Western drugmakers said they were seeking alternative routes into the Gulf Source: www.thehindu.com Medical Disclaimer: This content is ...
GLP-1 Drugs Show Growing Promise for Afib Control
(MedPage Today) -- For patients with obesity and atrial fibrillation (Afib), GLP-1 receptor agonist drugs may be the weight loss ...
GLP-1 Drugs May Benefit Cancer Patients With Brain Lesions
(MedPage Today) -- GLP-1 receptor agonist use was associated with a lower risk of death in cancer patients with brain ...
CDSCO issues advisory to prevent misleading promotion of prescription drugs for obesity
Activities that exaggerate therapeutic claims, guarantee weight-loss outcomes, or undermine the importance of lifestyle modifications such as diet and physical ...
Weight-loss drugs could also help manage addiction
A large study reports that popular GLP-1 agonists appear to have a positive effect in managing substance abuse as well. ...
Tale of Two Drugs: Wegovy Linked to Higher Risk of Blinding Eye Stroke vs Ozempic
(MedPage Today) -- The obesity drug semaglutide (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any ...
How duty cuts in cancer drugs will ease burden for patients
While private hospitals charge more than public facilities for cancer treatment, the relative financial burden is higher in the government ...
GLP-1 Drugs May Prevent, Treat Multiple Addictions
(MedPage Today) -- Initiation of a GLP-1 receptor agonist was tied to lower risks of several substance use disorders (SUDs) ...